Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy

Conclusions More extensive coverage of neo-CC is associated with a lower likelihood of development of macular atrophy in eyes receiving antivascular endothelial growth factor therapy, suggesting the protective effect of a type 1 MNV may be mediated by the development of a neo-CC and may provide insights into the biological significance of MNV as a response mechanism in eyes with age-related macular degeneration.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Original articles - Clinical science Source Type: research